Characterizing changes in muscle mass after radical nephrectomy for stage ii-iv clear cell renal cell carcinoma
Journal of Urology, September 2021
Impact of tobacco use on postoperative morbidity and mortality following surgery for renal masses
Journal of Urology, September 2021
Major adverse cardiovascular events following partial nephrectomy: a novel risk index
Journal of Urology, September 2021
The changing trends of image guided biopsy of small renal masses before intervention- an analysis of european multinational prospective eureca registry
Journal of Urology, September 2021
Oncologic outcomes following partial nephrectomy versus percutaneous cryoablation: a propensity score matched analysis
Journal of Urology, September 2021
End-stage kidney disease after partial and radical nephrectomy among patients with severe chronic kidney disease
Journal of Urology, September 2021
Association of tumor histology on impact of lymph node dissection on survival in t2-t3 renal cell carcinoma: analysis of the national cancer database
Journal of Urology, September 2021
Active surveillance in nonhereditary bilateral multifocal type i papillary renal cell carcinoma
Journal of Urology, September 2021
Impact of surgical approach (open vs. minimally invasive) on oncological outcomes after nephrectomy for localised renal cell carcinoma: a recur database project
Journal of Urology, September 2021
Surgeon-specific variation in operative outcomes for patients with clinical T1 renal masses
Journal of Urology, September 2021
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase III KEYNOTE-564 study
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management
European Urology, Volume 79, Issue 4, April 2021, Pages 468-477
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More